YD Bio Ltd reported $597K of revenue over the trailing twelve months, +17% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $597K (to FY2025). Net income: −$8.3M, trailing twelve months to FY2025. Free cash flow: −$8.0M, trailing twelve months to FY2025. Operating margin: −883%, trailing twelve months to FY2025.

YDESYD Bio Ltd

Healthcare

$2.42

$1.9652 weeks$20.09

YDES as reported

YD Bio Ltd reported $597K of revenue over the trailing twelve months, +17% on the year before. 9 reported series are charted on this page, each one as filed.

$597K

Revenue, trailing twelve months · to FY2025 · +17% against the twelve months before

Net income: −$8.3M
Net income · +489% year on year · trailing twelve months to FY2025
Free cash flow: −$8.0M
Free cash flow · +519% year on year · trailing twelve months to FY2025
Operating margin: −883%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for YDES, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$597K	+17%	FY2025
Net income	−$8.3M	+489%	FY2025
EPS	−$0.12	+500%	FY2025
Gross margin	28%	n/a	FY2025
Operating margin	−883%	n/a	FY2025
Net margin	−1393%	n/a	FY2025
ROE	291%	n/a	FY2025
ROA	−60%	n/a	FY2025
Free cash flow	−$8.0M	+519%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.